1,954
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study

ORCID Icon, ORCID Icon, , , , , ORCID Icon, , ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1973-1981 | Received 11 Dec 2020, Accepted 01 Feb 2021, Published online: 10 Mar 2021